A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
D Gu, Y Hu, H Ding, J Wei, K Chen, H Liu, M Zeng… - European …, 2019 - Springer
Objective To develop and validate a radiomics-based nomogram for preoperatively predicting grade 1 and grade 2/3 tumors in patients with pancreatic neuroendocrine tumors …
A Surov, HJ Meyer, A Wienke - Oncotarget, 2017 - ncbi.nlm.nih.gov
Diffusion weighted imaging (DWI) is a magnetic resonance imaging (MRI) technique based on measure of water diffusion in tissues. This diffusion can be quantified by apparent …
A Ramachandran, KS Madhusudhan - World Journal of …, 2022 - ncbi.nlm.nih.gov
Gastroenteropancreatic neuroendocrine neoplasms comprise a heterogeneous group of tumors that differ in their pathogenesis, hormonal syndromes produced, biological behavior …
B Morse, D Jeong, K Thomas, D Diallo, JR Strosberg - Pancreas, 2017 - journals.lww.com
Objective The aim of this study was to determine if magnetic resonance imaging (MRI) performed with hepatobiliary phase imaging results in higher lesion conspicuity and …
M Ingenerf, S Kiesl, S Karim, L Beyer, H Ilhan… - Cancers, 2021 - mdpi.com
Simple Summary TARE with 90Yttrium has become a valuable treatment option for patients with unresectable NELMs. However, early evaluation of therapy response remains …
J Gao, S Xu, H Ju, Y Pan, Y Zhang - EJNMMI research, 2023 - Springer
Background To evaluate the utility of 68Ga-DOTATATE and 18F-FDG PET/MR for prediction of grade and stage of pancreatic neuroendocrine tumors (PNETs), and to examine the …
T Moriya, K Saito, Y Tajima, TL Harada, Y Araki… - Cancer Imaging, 2017 - Springer
Background To evaluate the usefulness of differentiation of histological grade in hepatocellular carcinoma (HCC) using three-dimensional (3D) analysis of apparent diffusion …
A Surov, HJ Meyer, A Wienke - Oncotarget, 2018 - ncbi.nlm.nih.gov
Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin - PMC Back to Top Skip to main content NIH NLM Logo Access …